Aura Biosciences to Join Esteemed Healthcare Conference

November 25, 2025 - 02:42

BOSTON, Nov. 24, 2025 -- Aura Biosciences, Inc., a clinical-stage biotechnology firm focused on developing precision therapies for solid tumors, has announced its participation in the upcoming 8th Annual Evercore Healthcare Conference. The event is set to take place on Tuesday, December 2, 2025, at 10:50 a.m. ET.

Elisabet de los Pinos, PhD, the company's Chief Executive Officer, will engage in a fireside chat during the conference. This presentation will provide insights into Aura Biosciences' innovative approaches to treating solid tumors while prioritizing the preservation of organ function.

The participation in this prestigious conference highlights Aura Biosciences' commitment to advancing its therapeutic pipeline and fostering discussions around the future of oncology treatments. As the company continues to make strides in the biotechnology sector, this event serves as an opportunity for stakeholders to gain valuable perspectives on its ongoing projects and strategic vision.